Llwytho...
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
No specific therapy is available for COVID-19. We report the effectiveness and adverse effects of triple therapy with hydroxychloroquine, azithromycin, and ciclesonide in patients with COVID-19 pneumonia. The clinical condition of the patients improved within 5 days in response to the therapy.
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Microbiol Immunol Infect |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7534751/ https://ncbi.nlm.nih.gov/pubmed/33054978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmii.2020.09.003 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|